Arbutus Biopharma Corp Sustainability Reports
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing a cure for people with chronic hepatitis B virus infection.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 25490064CESONAUIAS23
FIGI: BBG001S6RSK0
3 reports from 2017 to 2021
